The Cutting Edge of Diagnosis and Treatment in Rheumatologic Disorders
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 28
Special Issue Editor
Interests: rheumatology; arthritis; autoimmune
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We invite submissions to our upcoming Special Issue focused on the most pressing challenges and innovations in diagnosing and treating rheumatologic diseases. Despite advances in imaging, serologic testing, and clinical scoring systems, early and accurate diagnosis remains elusive in many cases. This Special Issue seeks original research, reviews, and expert perspectives on emerging diagnostic approaches, including novel biomarkers, imaging modalities, and clinical tools, that may enable earlier intervention and improved patient outcomes.
We also welcome contributions that explore the evolving landscape of targeted therapies, including biologics, JAK inhibitors, and other disease-modifying agents. Submissions addressing efficacy, safety profiles, real-world data, and long-term survival impacts are especially encouraged. Through this Special Issue, we will highlight innovations that redefineclinical practice and enhance quality of life for patients living with rheumatologic disorders.
Dr. Ji-Hyoun Kang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiphospholipid syndrome (APS)
- hemolytic anemia
- lupus anticoagulant
- rheumatologic disorders
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
